Matches in Wikidata for { <http://www.wikidata.org/entity/Q45204211> ?p ?o ?g. }
- Q45204211 description "2005 nî lūn-bûn" @default.
- Q45204211 description "2005年の論文" @default.
- Q45204211 description "2005年学术文章" @default.
- Q45204211 description "2005年学术文章" @default.
- Q45204211 description "2005年学术文章" @default.
- Q45204211 description "2005年学术文章" @default.
- Q45204211 description "2005年学术文章" @default.
- Q45204211 description "2005年学术文章" @default.
- Q45204211 description "2005年學術文章" @default.
- Q45204211 description "2005年學術文章" @default.
- Q45204211 description "2005年學術文章" @default.
- Q45204211 description "2005年學術文章" @default.
- Q45204211 description "2005年學術文章" @default.
- Q45204211 description "2005년 논문" @default.
- Q45204211 description "article científic" @default.
- Q45204211 description "article scientific" @default.
- Q45204211 description "article scientifique" @default.
- Q45204211 description "articol științific" @default.
- Q45204211 description "articolo scientifico" @default.
- Q45204211 description "artigo científico" @default.
- Q45204211 description "artigo científico" @default.
- Q45204211 description "artigo científico" @default.
- Q45204211 description "artikel ilmiah" @default.
- Q45204211 description "artikull shkencor" @default.
- Q45204211 description "artikulong pang-agham" @default.
- Q45204211 description "artykuł naukowy" @default.
- Q45204211 description "artículo científico publicado en 2005" @default.
- Q45204211 description "artículu científicu" @default.
- Q45204211 description "bilimsel makale" @default.
- Q45204211 description "bài báo khoa học" @default.
- Q45204211 description "naučni članak" @default.
- Q45204211 description "scienca artikolo" @default.
- Q45204211 description "scientific article published in March 2005" @default.
- Q45204211 description "scientific article published in March 2005" @default.
- Q45204211 description "scientific article published in March 2005" @default.
- Q45204211 description "teaduslik artikkel" @default.
- Q45204211 description "tieteellinen artikkeli" @default.
- Q45204211 description "tudományos cikk" @default.
- Q45204211 description "vedecký článok" @default.
- Q45204211 description "vetenskaplig artikel" @default.
- Q45204211 description "videnskabelig artikel" @default.
- Q45204211 description "vitenskapelig artikkel" @default.
- Q45204211 description "vitskapeleg artikkel" @default.
- Q45204211 description "vědecký článek" @default.
- Q45204211 description "wetenschappelijk artikel" @default.
- Q45204211 description "wissenschaftlicher Artikel" @default.
- Q45204211 description "επιστημονικό άρθρο" @default.
- Q45204211 description "мақолаи илмӣ" @default.
- Q45204211 description "наукова стаття, опублікована в березні 2005" @default.
- Q45204211 description "научна статия" @default.
- Q45204211 description "научная статья" @default.
- Q45204211 description "научни чланак" @default.
- Q45204211 description "научни чланак" @default.
- Q45204211 description "מאמר מדעי" @default.
- Q45204211 description "مقالة علمية نشرت في مارس 2005" @default.
- Q45204211 description "মার্চ ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q45204211 description "บทความทางวิทยาศาสตร์" @default.
- Q45204211 description "სამეცნიერო სტატია" @default.
- Q45204211 name "Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma" @default.
- Q45204211 name "Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma" @default.
- Q45204211 type Item @default.
- Q45204211 label "Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma" @default.
- Q45204211 label "Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma" @default.
- Q45204211 prefLabel "Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma" @default.
- Q45204211 prefLabel "Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma" @default.
- Q45204211 P1433 Q45204211-CCEBEC4C-F336-42CE-88E5-BD13627EF8E5 @default.
- Q45204211 P1476 Q45204211-9594EFCD-31DC-4910-8A2C-9D133953C4FC @default.
- Q45204211 P2093 Q45204211-18498643-B77C-4CA1-A5AE-31ADC7B69E85 @default.
- Q45204211 P2093 Q45204211-326D4613-64F9-4A6C-853A-AF2A48A4118F @default.
- Q45204211 P2093 Q45204211-3AAB2399-DBF7-484D-9E49-BE8D7097006D @default.
- Q45204211 P2093 Q45204211-3BDCAB71-D2DD-49CB-A652-C45D60517E2B @default.
- Q45204211 P2093 Q45204211-511ADA18-DAC3-4150-95B5-9138F6A4DB02 @default.
- Q45204211 P2093 Q45204211-56FF01EF-E453-4C14-AAFB-CEB094E457EF @default.
- Q45204211 P2093 Q45204211-5969F32F-CB43-417B-93E4-0D04AD7AEDED @default.
- Q45204211 P2093 Q45204211-5CCFE66F-A4CB-4407-8E08-65AFF741B499 @default.
- Q45204211 P2093 Q45204211-63173159-423D-4691-938F-BCF2D766D3E4 @default.
- Q45204211 P2093 Q45204211-A9FDD26A-8431-445E-878B-61DCA44AD0C2 @default.
- Q45204211 P2093 Q45204211-B585F4E4-F2D5-4B91-8FA9-B6F60419DA2A @default.
- Q45204211 P2093 Q45204211-BE309BE9-3223-43AE-AC4E-BA8606F75777 @default.
- Q45204211 P2860 Q45204211-0E92E2DF-8531-4A44-82B3-ECBEE4C56E52 @default.
- Q45204211 P2860 Q45204211-5EFBDBA8-4861-42EA-AB9B-652BB1B6A377 @default.
- Q45204211 P2860 Q45204211-EAA30BB1-5D4C-477F-B9F1-373A00EFD6D5 @default.
- Q45204211 P304 Q45204211-13DCC2A4-2628-4435-A759-B745421965AA @default.
- Q45204211 P31 Q45204211-D4ED7840-FECB-4764-A7F8-B06CB6538C68 @default.
- Q45204211 P356 Q45204211-7CF504DC-A644-48B0-9A95-BB39AC7AE4F3 @default.
- Q45204211 P407 Q45204211-956B1560-9762-4140-82BD-30DB56B5479E @default.
- Q45204211 P433 Q45204211-FECFCB1A-A84F-4984-82FD-BB486913979F @default.
- Q45204211 P478 Q45204211-CB82E2D7-F365-464E-8B98-C7F1121B1AFE @default.
- Q45204211 P50 Q45204211-6FB6C24A-6912-488E-ADE8-1FE795E57AB6 @default.
- Q45204211 P577 Q45204211-9991D0EB-600A-4C96-8C01-6A4C9D402C6D @default.
- Q45204211 P698 Q45204211-9FE69F94-54CD-40A6-8950-C8F9D9589304 @default.
- Q45204211 P921 Q45204211-3BA90CF1-220B-413D-8240-CAFA5A566A1B @default.
- Q45204211 P921 Q45204211-DB038D75-ADDC-4ED2-9410-DBCE5ED35CBD @default.
- Q45204211 P356 10428190400013688 @default.
- Q45204211 P698 15621843 @default.
- Q45204211 P1433 Q6534493 @default.
- Q45204211 P1476 "Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma" @default.
- Q45204211 P2093 "Barulli S" @default.
- Q45204211 P2093 "D'Adamo F" @default.
- Q45204211 P2093 "Guiducci B" @default.